# PROTRACT (NCT04015622)

> PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04015622
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: British Columbia Cancer Agency
- Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Interventions: Enzalutamide; Docetaxel
- Enrollment: 100
- Primary outcome: Progression free survival (PFS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 6

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=protract-nct04015622